|
| |
Image Results
Loading...
Loading...
CANDESARTAN CILEXETIL Pages on BioPortfolio:
Results from other life science and pharmaceutical sites:
Candesartan - Wikipedia, the free encyclopedia
The prodrug candesartan cilexetil is marketed by AstraZeneca and Takeda ... Candesartan cilexetil is metabolised completely by esterases in the intestinal ...
http://en.wikipedia.org/wiki/Candesartan...
|
Atacand, Amias, Hytacand, (candesartan cilexetil) - angiotensin II ...
Atacand, Amias, Hytacand (candesartan cilexetil) information, an angiotensin II antagonist by AstraZeneca.
http://www.astrazeneca.com/medicines/?itemId=3887994...
|
Candesartan cilexetil reduces chronic renal allograft injury in ...
OBJECTIVES: To determine the effects of the angiotensin II receptor antagonist, candesartan cilexetil, on glomerular and systemic blood pressures and the ...
http://www.ncbi.nlm.nih.gov/pubmed/9493123...
|
New data on the effect of candesartan cilexetil on NYHA functional ...
9 Mar 2004 ... Of all CHARM patients, 35.4% taking candesartan cilexetil improved in NYHA functional class, 55.6% remained unchanged and 9% worsened.
http://www.takeda.com/press/article_828.html...
|
Candesartan cilexetil is not associated with cough in hypertensive ...
The aim of this study was to evaluate the occurrence of dry cough during treatment with candesartan cilexetil, enalapril, or placebo in patients with ...
http://www.ncbi.nlm.nih.gov/pubmed/10701823...
|
Clinical efficacy and tolerability of candesartan cilexetil
Clinical trials of candesartan cilexetil conducted in Japan are reviewed. Candesartan cilexetil inhibited the pressor response to intravenous angiotensin II ...
http://www.nature.com/jhh/journal/v13/n1s/abs/1000746a.html...
|
Candesartan cilexetil plus hydrochlorothiazide combination: a ...
The combination of candesartan cilexetil [an angiotensin II type 1 (AT(1)) receptor antagonist] plus hydrochlorothiazide (a thiazide diuretic), ...
http://www.ncbi.nlm.nih.gov/pubmed/11929332...
|
FDA Approves Candesartan Cilexetil for Use with an ACE Inhibitor ...
20 May 2005 ... OSAKA, JAPAN --- Takeda Pharmaceutical Company Limited ("Takeda") announced today that the US Food and Drug Administration (FDA) has ...
http://www.takeda.com/press/article_1109.html...
|
A forced titration study of antihypertensive efficacy of ...
A total of 611 patients with essential hypertension (diastolic blood pressure 95 to 114 mm Hg) were randomised initially to candesartan cilexetil 16 mg once ...
http://www.nature.com/jhh/journal/v15/n7/abs/1001205a.html...
|
The ACCESS Study: evaluation of Acute Candesartan Cilexetil ...
Schrader J, Lüders S, Kulschewski A, Berger J, Zidek W, Treib J, Einhäupl K, Diener HC, Dominiak P; Acute Candesartan Cilexetil Therapy in Stroke Survivors ...
http://www.ncbi.nlm.nih.gov/pubmed/12817109...
|
|